Net Medical Xpress (NMXS) stock price, revenue, and financials

Net Medical Xpress market cap is $2 m, and annual revenue was $3.05 m in FY 2016

$2 M

NMXS Mkt cap, 17-Sept-2020

$628 K

Net Medical Xpress Revenue Q3, 2017
Net Medical Xpress Gross profit (Q3, 2017)156 K
Net Medical Xpress Gross profit margin (Q3, 2017), %24.8%
Net Medical Xpress Net income (Q3, 2017)-55 K
Net Medical Xpress EBIT (Q3, 2017)-52 K
Net Medical Xpress Cash, 30-Sept-2017226 K
Net Medical Xpress EV1.8 M

Net Medical Xpress Revenue

Net Medical Xpress revenue was $3.05 m in FY, 2016

Embed Graph

Net Medical Xpress Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

3.2m3.9m4.8m4.6m4.2m3.0m

Cost of goods sold

2.5m3.0m3.7m3.8m3.1m2.3m

Gross profit

678.0k923.0k1.2m818.0k1.2m771.0k

Gross profit Margin, %

21%24%24%18%28%25%

R&D expense

66.0k70.0k156.0k121.0k100.0k87.0k

General and administrative expense

736.0k812.0k944.0k1.1m887.0k935.0k

Operating expense total

892.0k907.0k1.1m1.3m1.0m1.1m

Depreciation and amortization

19.0k15.0k12.0k12.0k

EBIT

(214.0k)16.0k42.0k(466.0k)160.0k(335.0k)

EBIT margin, %

(7%)0%1%(10%)4%(11%)

Interest expense

10.0k12.0k12.0k16.0k9.0k9.0k

Net Income

(224.0k)5.0k30.0k(482.0k)151.0k(344.0k)

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

758.0k719.0k923.0k960.0k964.0k1.2m1.2m1.2m1.3m1.2m1.1m1.2m1.1m1.0m918.0k827.0k651.0k731.0k666.0k628.0k

Cost of goods sold

626.0k567.0k717.0k743.0k727.0k916.0k927.0k909.0k982.0k959.0k928.0k923.0k850.0k642.0k629.0k643.0k524.0k542.0k493.0k472.0k

Gross profit

132.0k152.0k206.0k217.0k237.0k305.0k279.0k320.0k289.0k215.0k163.0k317.0k278.0k368.0k289.0k184.0k127.0k189.0k173.0k156.0k

Gross profit Margin, %

17%21%22%23%25%25%23%26%23%18%15%26%25%36%31%22%20%26%26%25%

R&D expense

14.0k16.0k20.0k16.0k15.0k16.0k45.0k45.0k40.0k30.0k29.0k40.0k26.0k26.0k22.0k13.0k30.0k22.0k22.0k18.0k

General and administrative expense

188.0k193.0k193.0k202.0k216.0k226.0k225.0k256.0k251.0k244.0k235.0k217.0k218.0k232.0k242.0k263.0k220.0k204.0k214.0k189.0k

Operating expense total

233.0k220.0k227.0k226.0k252.0k250.0k274.0k305.0k294.0k278.0k268.0k244.0k247.0k261.0k267.0k278.0k251.0k228.0k236.0k208.0k

Depreciation and amortization

8.0k4.0k4.0k3.0k4.0k4.0k3.0k3.0k3.0k5.0k2.0k3.0k2.0k1.0k

EBIT

(101.0k)(68.0k)(21.0k)(9.0k)(15.0k)55.0k5.0k15.0k(5.0k)(63.0k)(105.0k)73.0k31.0k107.0k22.0k(94.0k)(124.0k)(39.0k)(63.0k)(52.0k)

EBIT margin, %

(13%)(9%)(2%)(1%)(2%)5%0%1%0%(5%)(10%)6%3%11%2%(11%)(19%)(5%)(9%)(8%)

Interest expense

3.0k3.0k2.0k3.0k4.0k2.0k4.0k3.0k4.0k4.0k4.0k2.0k2.0k2.0k2.0k3.0k2.0k2.0k3.0k3.0k

Net Income

(104.0k)(71.0k)(23.0k)(12.0k)(19.0k)53.0k1.0k12.0k(9.0k)(67.0k)(109.0k)71.0k29.0k105.0k20.0k(97.0k)(126.0k)(41.0k)(66.0k)(55.0k)

Net Medical Xpress Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

100.0k109.0k421.0k277.0k410.0k307.0k

Accounts Receivable

463.0k653.0k606.0k581.0k429.0k256.0k

Prepaid Expenses

41.0k61.0k66.0k65.0k76.0k

Inventories

5.0k2.0k33.0k27.0k20.0k

Current Assets

604.0k828.0k1.1m956.0k942.0k653.0k

PP&E

75.0k55.0k58.0k40.0k16.0k

Goodwill

239.0k239.0k239.0k159.0k

Total Assets

683.0k887.0k1.4m1.2m1.2m820.0k

Accounts Payable

634.0k632.0k676.0k764.0k439.0k320.0k

Short-term debt

13.0k3.0k7.0k28.0k14.0k

Current Liabilities

696.0k773.0k812.0k916.0k609.0k467.0k

Long-term debt

4.0k1.0k11.0k9.0k1.0k

Non-Current Liabilities

6.0k3.0k13.0k11.0k1.0k1.0k

Total Debt

17.0k4.0k18.0k37.0k6.0k

Total Liabilities

702.0k776.0k825.0k927.0k610.0k467.0k

Common Stock

147.0k157.0k160.0k175.0k175.0k

Additional Paid-in Capital

15.2m15.4m15.5m16.0m16.0m16.3m

Retained Earnings

(15.3m)(15.3m)(15.3m)(15.8m)(15.6m)(16.0m)

Total Equity

(19.0k)111.0k571.0k312.0k591.0k353.0k

Debt to Equity Ratio

-0.9 x0 x0 x0.1 x0 x

Debt to Assets Ratio

0 x0 x0 x0 x0 x

Financial Leverage

-35.9 x8 x2.4 x4 x2 x2.3 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

113.0k97.0k113.0k63.0k183.0k192.0k184.0k413.0k371.0k432.0k315.0k409.0k396.0k605.0k325.0k387.0k428.0k271.0k265.0k226.0k

Accounts Receivable

471.0k438.0k555.0k596.0k580.0k758.0k742.0k639.0k741.0k653.0k883.0k521.0k558.0k344.0k597.0k488.0k233.0k336.0k246.0k231.0k

Prepaid Expenses

28.0k34.0k18.0k149.0k107.0k36.0k164.0k118.0k40.0k140.0k108.0k43.0k150.0k107.0k50.0k146.0k104.0k49.0k126.0k90.0k

Inventories

15.0k7.0k10.0k9.0k12.0k14.0k15.0k14.0k15.0k22.0k23.0k25.0k20.0k22.0k20.0k18.0k18.0k

Current Assets

612.0k569.0k686.0k823.0k877.0k996.0k1.1m1.2m1.2m1.2m1.3m988.0k1.1m1.1m997.0k1.0m787.0k676.0k655.0k565.0k

PP&E

77.0k74.0k73.0k66.0k61.0k45.0k44.0k42.0k54.0k54.0k48.0k35.0k28.0k22.0k11.0k6.0k3.0k2.0k8.0k

Goodwill

239.0k239.0k239.0k239.0k239.0k239.0k239.0k239.0k239.0k239.0k159.0k159.0k159.0k

Total Assets

693.0k647.0k763.0k893.0k942.0k1.0m1.1m1.5m1.5m1.5m1.6m1.3m1.4m1.3m1.3m1.3m1.0m839.0k820.0k736.0k

Accounts Payable

628.0k584.0k632.0k587.0k653.0k723.0k642.0k676.0k709.0k736.0k784.0k678.0k670.0k520.0k471.0k485.0k384.0k382.0k355.0k349.0k

Short-term debt

12.0k12.0k10.0k7.0k5.0k3.0k2.0k2.0k6.0k8.0k8.0k8.0k8.0k8.0k18.0k15.0k12.0k2.0k

Current Liabilities

708.0k664.0k709.0k824.0k857.0k854.0k875.0k883.0k841.0k972.0k1.2m827.0k904.0k721.0k613.0k722.0k564.0k523.0k570.0k536.0k

Long-term debt

11.0k8.0k3.0k3.0k2.0k10.0k13.0k11.0k7.0k5.0k3.0k5.0k

Non-Current Liabilities

11.0k8.0k5.0k3.0k2.0k2.0k2.0k2.0k10.0k15.0k13.0k9.0k7.0k5.0k5.0k

Total Debt

23.0k20.0k13.0k10.0k7.0k3.0k2.0k2.0k16.0k21.0k19.0k15.0k20.0k20.0k11.0k10.0k9.0k7.0k

Total Liabilities

719.0k672.0k714.0k827.0k859.0k856.0k877.0k885.0k851.0k987.0k1.2m836.0k911.0k726.0k613.0k722.0k564.0k523.0k570.0k541.0k

Common Stock

145.0k147.0k157.0k157.0k157.0k159.0k160.0k160.0k160.0k163.0k163.0k175.0k175.0k175.0k175.0k19.0k19.0k20.0k20.0k20.0k

Additional Paid-in Capital

15.1m15.1m15.4m15.4m15.4m15.4m15.5m15.5m15.5m15.7m15.7m16.0m16.0m16.0m16.0m16.2m16.2m16.3m16.3m16.3m

Retained Earnings

(15.2m)(15.3m)(15.4m)(15.4m)(15.4m)(15.3m)(15.3m)(15.3m)(15.3m)(15.4m)(15.5m)(15.7m)(15.7m)(15.6m)(15.6m)(15.7m)(15.8m)(16.0m)(16.1m)(16.1m)

Total Equity

(26.0k)(25.0k)49.0k66.0k83.0k189.0k270.0k582.0k612.0k550.0k446.0k430.0k486.0k618.0k638.0k568.0k469.0k316.0k250.0k195.0k

Debt to Equity Ratio

-0.9 x-0.8 x0.3 x0.2 x0.1 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x

Debt to Assets Ratio

0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x

Financial Leverage

-26.7 x-25.9 x15.6 x13.5 x11.3 x5.5 x4.2 x2.5 x2.4 x2.8 x3.6 x2.9 x2.9 x2.2 x2 x2.3 x2.2 x2.7 x3.3 x3.8 x

Net Medical Xpress Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(224.0k)5.0k30.0k(482.0k)151.0k(344.0k)

Depreciation and Amortization

7.0k19.0k26.0k27.0k12.0k12.0k

Accounts Receivable

60.0k196.0k(47.0k)(25.0k)(152.0k)(173.0k)

Inventories

5.0k(3.0k)31.0k(6.0k)(7.0k)

Accounts Payable

(13.0k)(2.0k)44.0k108.0k(339.0k)(119.0k)

Cash From Operating Activities

(101.0k)(58.0k)243.0k(179.0k)131.0k(80.0k)

Purchases of PP&E

43.0k8.0k(12.0k)(9.0k)

Cash From Investing Activities

(43.0k)(8.0k)(12.0k)(9.0k)

Long-term Borrowings

(10.0k)13.0k(3.0k)

Cash From Financing Activities

56.0k75.0k81.0k44.0k2.0k(23.0k)

Net Change in Cash

(88.0k)9.0k312.0k(144.0k)133.0k(103.0k)

Interest Paid

11.0k9.0k13.0k7.0k

Net Medical Xpress Ratios

USDQ2, 2011

Debt/Equity

-0.9 x

Financial Leverage

-26.7 x